This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in healthcare expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Outcomes were analyzed using generalized estimating equation (GEE) models with AR(1) working correlation to compare adjusted mean total and out-of-pocket expenditures, inpatient utilization, and mental and physical HRQL across multimorbidity profiles while controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined throughout the study years, highlighting the growing humanistic toll of chronic disease clustering. These findings provide longitudinal evidence of persistent disparities associated with multimorbidity and may inform future research and health system planning strategies. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.
This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in health care expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Mean adjusted total and out-of-pocket expenditures, inpatient visits, and mental HRQL scores were compared using regression models controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined across the study years, highlighting the growing humanistic toll of chronic disease clustering. These patterns underscore the need for policies that promote integrated care models, chronic disease prevention, and financial protection strategies for adults with multiple conditions. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.
Background/Objectives: Multimorbidity is associated with substantial healthcare burdens, but its associations with health and economic outcomes among young adults remain poorly characterized. This study examined associations between clinically defined multimorbidity profiles and expenditures, catastrophic healthcare expenditure, health-related quality of life, and inpatient utilization across adult life stages. Methods: Medical Expenditure Panel Survey Panel 24 data were analyzed for 4331 U.S. adults followed from 2019 through 2022, including 942 young adults. Respondents were classified into five profiles: no included conditions, respiratory only, cardiometabolic only, any-cancer involved, and cardiorespiratory. Longitudinally weighted generalized estimating equations were fitted. Results: Profile distribution differed significantly across age groups. Among young adults, overall profile and profile-by-year tests were nonsignificant for total expenditures and most other outcomes. In 2019, the cardiorespiratory profile was associated with higher expected expenditures than no included conditions (expenditure ratio = 3.44, 95% CI: 1.59–7.46; p = 0.002). It was also associated with higher hospitalization odds across 2019–2022 (OR = 3.39, 95% CI: 1.28–8.99; p = 0.014), although the overall profile test was nonsignificant. Sex, insurance, and income were associated with several outcomes. Mental health scores were lower in 2021 and 2022 than in 2019 within the reference profile, without evidence of uniform changes across profiles. Conclusions: Overall profile effects were not consistently demonstrated among young adults. Parameter-specific cardiorespiratory estimates suggested a potentially elevated burden but remained exploratory because of sparse observations and nonsignificant overall tests. Socioeconomic vulnerability remained an important correlate of healthcare burden.